QA: ELI LILLY & Co in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000059478_2022_ELI_LILLY_Co.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000059478, ELI LILLY & Co

  xvar xval
0 AssetsCurrent 18,452,400,000
1 IntangibleAssetsNetIncludingGoodwill 11,583,900,000
2 PropertyPlantAndEquipmentNet 8,985,100,000
3 remainder_Assets 9,784,600,000
4 LiabilitiesCurrent 15,052,700,000
5 LiabilitiesNoncurrent 24,598,500,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 7,312,800,000
8 SellingGeneralAndAdministrativeExpense 6,431,600,000
9 ResearchAndDevelopmentExpense 7,025,900,000
10 remainder_Expenses 1,966,400,000
11 remainder_Revenues 28,318,400,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 2,153,300,000
  yvar yval
0 Assets 48,806,000,000
1 Liabilities 39,651,200,000
2 Expenses 22,736,700,000
3 Revenues 28,318,400,000
4 StockholdersEquity 9,154,800,000
5 NetIncome 5,581,700,000
6 ComprehensiveNetIncome 6,658,350,000
7 BaseVar 70,832,800,000
8 EconomicCapitalRatio 0.507

Edgar->Model Mapping

Feature Distribution

Change over Time